![Loretta Tse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Loretta Tse worked as a Managing Director at the Fred Hutchinson Cancer Research Center.
She also served as a Director of Business Development at Mergen Ltd. and as an Associate at Oxford Bioscience Partners.
Additionally, she worked as a Senior Analyst at Tekla Capital Management LLC from 2015 to 2022.
Prior to that, she was a Business Development Manager at Strata BioSciences, Inc. Dr. Tse completed her undergraduate degree at the University of California, Davis.
| Unternehmen | Position | Ende |
|---|---|---|
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Corporate Officer/Principal | 30.06.2015 |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Analyst-Equity | - |
Mergen Ltd.
 Mergen Ltd. BiotechnologyHealth Technology Operates as a biotech company which designs and produces pre-spotted and custom arrays of human, mouse, rat, and bacterial genomes | Corporate Officer/Principal | - |
Strata BioSciences, Inc.
 Strata BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genomic services using high-throughput gene knockout technologies | Corporate Officer/Principal | - |
Oxford Bioscience Partners
 Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Private-Equity-Analyst | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 6 |
|---|---|
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Strata BioSciences, Inc.
Strata BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides genomic services using high-throughput gene knockout technologies | Commercial Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
Mergen Ltd.
Mergen Ltd. BiotechnologyHealth Technology Operates as a biotech company which designs and produces pre-spotted and custom arrays of human, mouse, rat, and bacterial genomes | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
